New connectivity captures data at its source, reducing manual burden and enabling broader value across patient care, research and biopharma collaboration FREMONT, Calif., April 21, 2026 ...
Following the U.S. FDA’s March 11 approval of Novo Nordisk A/S’ glucagon-like peptide 1 receptor agonist, Wegovy (semaglutide), to reduce the risk of major ...
Regardless of the considerable experience with PBSC collection in adults, apheresis in low-weight children remains challenging. The main obstacles are difficulties in obtaining adequate venous access, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results